Financhill
Sell
38

RANI Quote, Financials, Valuation and Earnings

Last price:
$1.39
Seasonality move :
1.43%
Day range:
$1.35 - $1.47
52-week range:
$0.39 - $3.87
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
43.48x
P/B ratio:
9.60x
Volume:
3M
Avg. volume:
2.8M
1-year change:
-1.41%
Market cap:
$136.6M
Revenue:
$1M
EPS (TTM):
-$0.79

Earnings Data

Next earnings date for RANI
Mar 31
2026
Most recent earnings per share
-$0.12
Beat by $0.01
(Nov 6/2025)
Consensus Estimate
-$0.12
(Nov 6/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

RANI Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2026 Q4 $5M -- -- -$0.01 --
11/06/2025 Q3 -- -- -$0.12 -$0.12 $0.01
08/07/2025 Q2 -- -- -$0.18 -$0.20 $0.01
05/13/2025 Q1 -- $172K -$0.22 -$0.24 $0.02
03/31/2025 Q4 -- $1M -$0.27 -$0.23 -$0.05
11/14/2024 Q3 -- -- -$0.24 -$0.29 $0.06
08/06/2024 Q2 -- -- -$0.26 -$0.29 $0.03
05/06/2024 Q1 -- -- -$0.29 -$0.23 -$0.06
03/20/2024 Q4 -- -- -$0.27 -$0.34 $0.06
11/08/2023 Q3 -- -- -$0.36 -- --
08/11/2023 Q2 -- -- -$0.37 -- --
05/10/2023 Q1 -- -- -$0.33 -- --
03/22/2023 Q4 -- -- -$0.35 -- --
11/10/2022 Q3 -- -- -$0.33 -- --
08/10/2022 Q2 -- -- -$0.31 -- --
05/11/2022 Q1 -- -- -$0.29 -- --
03/29/2022 Q4 -- -- -$0.26 -- --
11/15/2021 Q3 -- -- -$0.16 -- --
09/13/2021 Q2 -- $2M -- -- --
03/31/2021 Q1 -- $756K -- -- --
12/31/2020 Q4 -- $210K -- -- --
09/30/2020 Q3 -- $108K -- -- --
06/30/2020 Q2 -- $60K -$0.14 -- --
03/31/2020 Q1 -- $83K -$0.27 -- --

Rani Therapeutics Holdings, Inc. Earnings Questions

  • How Much did Rani Therapeutics Holdings, Inc. Generate in Revenue Last Quarter?

    Rani Therapeutics Holdings, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Rani Therapeutics Holdings, Inc. Beat Earnings Last Quarter?

    Rani Therapeutics Holdings, Inc. announced earnings per share of -$0.12 which represents a beat of analyst forecast a -$0.12 per share.

  • Is Rani Therapeutics Holdings, Inc. Profitable?

    Rani Therapeutics Holdings, Inc. reported -$223K that represents -$0.00 per share over the last quarter.

  • What is the Analyst Consensus for Rani Therapeutics Holdings, Inc. EPS Next Year?

    Rani Therapeutics Holdings, Inc.'s earnings are forecast to decrease from -$1.05 per share to -$1.00 per share next year representing a decrease of -66.8%.

  • When is Rani Therapeutics Holdings, Inc.'s Earnings Date?

    Rani Therapeutics Holdings, Inc.'s next earnings date is March 31, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
72
GLTO alert for Dec 29

Galecto, Inc. [GLTO] is down 12.13% over the past day.

Sell
20
SMX alert for Dec 29

SMX (Security Matters) Plc [SMX] is down 27.67% over the past day.

Sell
11
CDNAF alert for Dec 29

Canadian Tire Corp. Ltd. [CDNAF] is up 11.94% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock